Publications by authors named "ZePing Zhou"

Claim this Profile
A
A retrospective study of risk factors for thrombosis in patients with ITP.
Fan Zhou, Shiqi Zhang, Renxia Li, Zhihui Feng, Dandan Wang, Zeping Zhou

Hematology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of immune thrombocytopenia in Yunnan Province and cytokine expression characteristics at different altitudes.
Wen Yang, Jianfang Dong, Wei Zhang, Yaxian Tan, Fan Zhou, Zeping Zhou

Hematology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese guidance for the clinical application of adeno-associated virus vector-based gene therapy for hemophilia B (2025).
Feng Xue, Yu Hu, Renchi Yang, Jing Sun, Linhua Yang, Hu Zhou, Zeping Zhou, Rongfu Zhou

Blood Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of hyperthyroidism on the hematopoietic system.
Wen Yang, Yanting Li, Li Ma, Yaxian Tan, Fan Zhou, Zeping Zhou

Clin Exp Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials.
Feng Xue, Mankai Ju, Tienan Zhu, Zeping Zhou, Jing Sun, Hu Zhou

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy, safety, and pharmacokinetics of N8-GP in previously treated Chinese patients with haemophilia A: results from the phase 3b pathfinder10 study.
Runhui Wu, Yun Chen, Wenqian Li, Jing Sun, Feng'e Yang, Zeping Zhou

Blood Coagul Fibrinolysis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of mitoxantrone hydrochloride liposome containing regimens in acute myeloid leukemia.
Tie-Jun Gong, Wei-Ming Li, Li Liu, Yu-Qing Chen, Su-Jun Gao, Ze-Ping Zhou

Oncologist· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial.
Yunfei Chen, Yanmei Xu, Jiawen Dai, Ting Sun, Huiyuan Li, Zeping Zhou, Hu Zhou

BMJ· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax combined with homoharringtonine, cytarabine and aclacinomycin as induction therapy in newly diagnosed Chinese acute myeloid leukaemia patients: A multicentre phase II study.
Yaxian Tan, Xingli Zhao, Xiaohui Suo, Guanchen Bai, Weihua Zhao, Zeping Zhou

Br J Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-optimised recombinant human thrombopoietin eltrombopag in patients with immune thrombocytopenia: a multicenter, randomised controlled trial (The TE-ITP Study).
Yunfei Chen, Ting Sun, Da Gao, Wei Wang, Zeping Zhou, Hu Zhou

EClinicalMedicine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone disease.
Yutong Wang, Qiming Xu, Yuan Li, Yongbin Su, Ling Wang, Zeping Zhou, Fuling Zhou

Cancer Pathog Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety analysis of China's first 10% IVIg (RonsenGlob) therapy in treating adult ITP.
Lijun Fang, Ting Sun, Hu Zhou, Guitao Jie, Jiaping Fu, Zeping Zhou

Ann Hematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between thyroid hormone levels and the incidence and staging of bladder cancer.
Jia Wang, Lu Yang, Shigang Du, Yi Pan, Ling Zhao, Zeping Zhou

Eur J Med Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of CD83 in the pathogenesis of immune thrombocytopenia.
Xiuli Wang, Qiyuan Zhou, Wen Yang, Hui Bi, Honghui Wang, Yongchun Zhou, Zeping Zhou

Hematology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study.
Yi Zhang, Hu Zhou, Shanshan Suo, Junling Zhuang, Linhua Yang, Zeping Zhou

Blood Cancer J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy.
Xiaoshuai Zhang, Bingcheng Liu, Jian Huang, Yanli Zhang, Na Xu, Zeping Zhou, Li Zhou

Blood· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The modified melphalan and busulfan-based regimen combined with maintenance therapy improved the survival of patients with refractory/relapsed AML after allogeneic transplantation: middle-term outcome of a multicenter trial.
Shulian Chen, Xiaoyu Zhang, Ting Niu, Yajing Xu, Guangxun Gao, Zeping Zhou, Fang Zhou, Sizhou Feng

Am J Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study.
Yu Hu, Xiaofan Liu, Hu Zhou, Shujie Wang, Ruibin Huang, Zeping Zhou

Lancet Haematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia following remission of AIDS-associated extra-nodal NK/T-cell lymphoma.
Shanshan Fan, Qiwen Zhou, Zeping Zhou, Danqing Wang, Sen Lin

Heliyon· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study.
Xiaoshuai Zhang, Na Xu, Yunfan Yang, Hai Lin, Bingcheng Liu, Zeping Zhou, Li Zhou

Clin Lymphoma Myeloma Leuk· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study.
Min Xu, Jinhui Shu, Shenxian Qian, Jingming Guo, Yuping Gong, Zeping Zhou, Hu Zhou

Lancet Reg Health West Pac· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis.
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Zeping Zhou

Am J Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes.
Jie Tian, Yong-Ping Song, Gao-Chong Zhang, Shu-Fang Wang, Xiao-Xiang Chu, Ze-Ping Zhou

J Cancer Res Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful hip arthroplasty in a patient with combined deficiency of factor V and factor FVIII.
Wen Yang, Hongli Mu, Fan Zhou, Jia Wang, Hui Bi, Zeping Zhou

Haemophilia· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of high dose recombinant human thrombopoietin in the treatment of immune thrombocytopenia.
Xiuli Wang, Hui Bi, Lin Liu, Yuebo Liu, Liefen Yin, Zeping Zhou

Platelets· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis